<?xml version="1.0" ?>
<document id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75">
  <chunk id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c0" text="molecules Benzylidene-bis-(4-Hydroxycoumarin) and Benzopyrano- Coumarin Derivatives: Synthesis, 1 H/ 13 C-NMR Conformational and X-ray Crystal Structure Studies and In Vitro Antiviral Activity Evaluations">
    <entity charOffset="0-9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c0.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="63-71" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c0.e1" ontology_id="CHEBI_28794" text="Coumarin" type="chemical"/>
    <entity charOffset="174-183" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c0.e2" ontology_id="CHEBI_22587" text="Antiviral" type="chemical"/>
  </chunk>
  <chunk id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c1" text="We report on the synthesis of 4-hydroxycoumarin dimers 1-15 bearing an aryl substituent on the central linker and fused benzopyranocoumarin derivatives 16-20 and on their in vitro broad anti-DNA and RNA virus activity evaluations. The chemical identities and structure of compounds 1-20 were deduced from their homo-and heteronuclear NMR measurements whereas the conformational properties of 5, 14 and 20 were assessed by the use of 1D difference NOE enhancements. Unequivocal proof of the stereostructure of compounds 7, 9, 16 and 18 was obtained by single crystal X-ray diffraction method. The">
    <entity charOffset="30-47" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c1.e0" ontology_id="CHEBI_40070" text="4-hydroxycoumarin" type="chemical"/>
    <entity charOffset="199-202" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c1.e1" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
  </chunk>
  <chunk id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2" text="Molecules 2011, 16 6024 X-ray crystal structure analysis revealed that two 4-hydroxycoumarin moieties in the 4-trifluoromethylphenyl-and 2-nitrophenyl derivatives (compounds 7 and 9, respectively) are intramolecularly hydrogen-bonded between hydroxyl and carbonyl oxygen atoms. Consequently, the compounds 7 and 9 adopt conformations in which two 4-hydroxycoumarin moieties are anti-disposed. Antiviral activity evaluation results indicated that the 4-bromobenzylidene derivative of bis-(4-hydroxycoumarin) (compound 3) possesses inhibitory activity against HSV-1 (KOS), HSV-2 (G), vaccinia virus and HSV-1 TK -KOS (ACV r ) at a concentration of 9-12 μM and at a minimum cytotoxic concentration (MCC) greater than 20 μM. Compounds 4-6, 8, and 20 were active against feline herpes virus (50% effective concentration, EC 50 = 5-8.1 μM), that is at a 4-7-fold lower concentration than the MCC.">
    <entity charOffset="0-9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e0" ontology_id="CHEBI_25367" text="Molecules" type="chemical"/>
    <entity charOffset="75-92" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e1" ontology_id="CHEBI_40070" text="4-hydroxycoumarin" type="chemical"/>
    <entity charOffset="242-250" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e2" ontology_id="CHEBI_29191" text="hydroxyl" type="chemical"/>
    <entity charOffset="242-250" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e3" ontology_id="CHEBI_43176" text="hydroxyl" type="chemical"/>
    <entity charOffset="255-263" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e4" ontology_id="CHEBI_23019" text="carbonyl" type="chemical"/>
    <entity charOffset="264-270" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e5" ontology_id="CHEBI_15379" text="oxygen" type="chemical"/>
    <entity charOffset="347-364" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e6" ontology_id="CHEBI_40070" text="4-hydroxycoumarin" type="chemical"/>
    <entity charOffset="393-402" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e7" ontology_id="CHEBI_22587" text="Antiviral" type="chemical"/>
    <entity charOffset="578-581" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e8" ontology_id="CHEBI_144460" text="Gaa" type="chemical"/>
    <entity charOffset="582-590" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" ontology_id="DOID_3298" text="vaccinia" type="disease"/>
    <entity charOffset="616-619" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e10" ontology_id="CHEBI_28496" text="ACV" type="chemical"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e0" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p0" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e1" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p1" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e2" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p2" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e3" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p3" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e4" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p4" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e5" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p5" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e6" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p6" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e7" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p7" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e8" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p8" relation="true"/>
    <pair e1="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e9" e2="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.e10" id="5b9c63d5acc2fe8fde000803aca5a7e6a0d6df75.c2.p9" relation="true"/>
  </chunk>
</document>
